Skip to main content
Close

INDICATIONS: TYMLOS is a prescription medicine used to treat osteoporosis in men and postmenopausal women who are at high risk for fracture. See more

TYMLOS is a prescription medicine used to:

  • Treat osteoporosis in postmenopausal women who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well. TYMLOS can decrease the chance of having a fracture of the spine and other bones in postmenopausal women with thinning and weakening bones (osteoporosis).
  • Increase bone density in men with osteoporosis who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well.

It is not known if TYMLOS is safe and effective for children and young adults 18 years and younger. TYMLOS should not be used in children and young adults whose bones are still growing. Close

Ready to learn more and
see how you could start
rebuilding bone today?

For men and postmenopausal women with
osteoporosis at high risk for fracture

TYMLOS Welcome Kit
*Pen not included.

Thank you for
signing up!

We will get in touch with you soon.



Your form has successfully been submitted. A confirmation will be sent to the email provided.

If you do not receive a confirmation email please call 1-855-730-8591 anytime Monday through Friday, 8 AM to 7 PM ET

For men and postmenopausal women
with osteoporosis at high risk for fracture

Not actual patient
Middle-aged man smiling at camera while in airport. Not actual patient
Not actual patient

For men and postmenopausal women
with osteoporosis at high risk for fracture

Here’s where you can start the process to receive the support that best fits your needs.
You can register for 1-on-1 assistance and training from our Clinical Educators, get our
travel-ready injection Welcome Kit, and sign up for the latest TYMLOS news and updates.
To begin, please provide the necessary information below.

All fields are required unless otherwise indicated.

Are you currently a patient with osteoporosis taking TYMLOS?

Please select a response.


You may sign up to receive emails by filling out the fields below. You must be taking or have been prescribed TYMLOS
to connect with a Clinical Educator or request a Welcome Kit.

Please select what you're interested in doing today: Select all

Please select at least one option.
Please enter your first name.
Please enter your last name.
Please enter your street address.
Please enter your city.
Please enter the valid 2-letter abbreviation for your state or U.S. territory.
Please enter a valid 5-digit ZIP Code.
Why do we need this?
Please enter your date of birth as MM/DD/YYYY.
Please enter your birthday certifying you are at least 18 years of age.
Close tooltip

This information is used to help determine your eligibility for the TYMLOS Clinical Educator Program.

Please enter a valid phone number.

PREFERRED LANGUAGE (optional)

Please enter your preferred language.

Please read the agreements below and select both checkboxes to sign up.

TYMLOS Clinical Educator Program Terms

I understand that the TYMLOS Clinical Educator Network program is staffed by Radius Clinical Educators who are product experts and who will guide me on how to use the TYMLOS injection pens. I acknowledge that these Clinical Educators do not replace my medical care team, and no medical advice will be provided to me through this program. The program is intended solely to support proper product use and patient access. It does not offer medical advice or clinical decision-making support. All treatment decisions remain the sole responsibility of my prescribing healthcare provider.

The guidance provided by Clinical Educators is consistent with the U.S. FDA-approved Prescribing Information for TYMLOS. I understand that I should read the Medication Guide and Instructions for Use that accompany the product.

I understand that my assigned Clinical Educator may refer me to other Radius agents and vendors (collectively, the "Radius Reimbursement Team") who may liaise with my insurance provider and medical care team. The Radius Reimbursement Team are access experts who may assist me in understanding my insurance coverage, the prior authorization process, and any potential eligibility for co-pay support. I understand that the Radius Reimbursement Team is not a healthcare provider, insurer, or financial advisor, and does not negotiate coverage or guarantee benefits. All final coverage decisions are made by my insurance provider.

I further understand that the Radius and the Radius Reimbursement Team do not have control over my insurance coverage, benefits, or financial liability and that my coverage and financial responsibility are subject to change. Enrollment in this program does not constitute a promise or guarantee that TYMLOS will be covered by my insurance or that my co-pay obligations will be acceptable. My financial obligations may be affected by other therapies that are not Radius medicines and not supported by this program.

I acknowledge that the TYMLOS Clinical Educator Network program is funded by Radius. Sessions may also include individuals from Radius who are not Clinical Educators or members of the Radius Reimbursement Team, but who may observe sessions to provide feedback and improve the program. These individuals will not actively participate in the sessions.

I consent to be contacted by Radius Clinical Educators or the Radius Reimbursement Team via mail, email, telephone, or text message (if I provide consent) in relation to the TYMLOS Clinical Educator Network program.

I understand that my participation in this program is voluntary. I am not required to enroll in this program or receive these communications, and I can still receive TYMLOS as prescribed by my healthcare provider. I may opt out of the service at any time by informing my Clinical Educator or the Radius Reimbursement Team.

I certify that I am at least eighteen (18) years of age and that my healthcare provider has prescribed TYMLOS to me and provided me with appropriate medical guidance regarding this treatment.

I understand that the program may be revised, changed, or terminated at any time without prior notice.

Please scroll completely through the terms above and select the checkbox to continue.

You must scroll completely through the terms above before accepting.



Authorization to Use and Disclose Health Information

By checking the checkbox below, I authorize my healthcare providers and staff, as well as any specialty pharmacies that dispense my medication, to disclose to Radius Health, Inc. and its affiliates, contractors, and agents (“Radius”), health information about me. This includes information related to my medical condition and treatment, health insurance coverage and claims, and prescriptions (including fill/refill information) (my “Health Information”).

I understand this may include information considered sensitive personal information, such as my health conditions, and that the use of this information by Radius is necessary to administer the education and access support services I am requesting. The collection, use, and disclosure of my Health Information will be for the purposes outlined below or as otherwise described in Radius’s Privacy Policy (opens in a new tab):

  • Enrolling me in the TYMLOS Clinical Educator Network program;
  • Informing me about the status of my prescription and fulfillment;
  • Providing live virtual training on the use of the TYMLOS self-injection pen;
  • Contacting my healthcare provider regarding Prior Authorizations or other insurance requirements;
  • Referring me to other support programs that Radius may offer;
  • Using aggregated or de-identified data to improve support services, training programs, and compliance monitoring.

I understand that I am not required to sign this Authorization and that my decision will not affect my treatment, payment, or eligibility with my healthcare provider or insurer. I understand that information disclosed under this Authorization may be re-disclosed by the recipient and may no longer be protected under federal or state privacy laws.

If I do not agree to this Authorization, or if I later revoke my consent, I understand I will not be able to participate in the TYMLOS Clinical Educator Network program or receive its related support services.

This Authorization will remain in effect for five (5) years from the date of my signature or until I am no longer participating in the program, whichever is sooner. Cancellation of this Authorization will not affect Radius’s ability to use or disclose Health Information received prior to the date of revocation.

Please scroll completely through the terms above and select the checkbox to continue.

You must scroll completely through the terms above before accepting.

TYMLOS Clinical Educator Network 1-on-1 help for patientsTYMLOS Clinical Educator Network 1-on-1 help for patients
Tymlos support icon

Ready to talk about TYMLOS with your doctor?

If you’re at a high risk for fracture due to osteoporosis, we can help start the conversation

Download our guide (opens in a new tab)
Support icon

Discover all the
support for access
and savings
TYMLOS offers

View coverage
Patient Brochure icon

Get our patient
brochure

Learn more about treating
osteoporosis with TYMLOS

IMPORTANT SAFETY INFORMATION

OpenClose

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about TYMLOS?

TYMLOS may cause serious side effects including: Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma.

  • Tell your healthcare provider right away if you have pain in your bones, pain in any areas of your body that does not go away, or any new or unusual lumps or swelling under your skin that is tender to touch.

Do not take TYMLOS: if you had an allergic reaction to abaloparatide or any of the other ingredients in TYMLOS. The inactive ingredients in TYMLOS are phenol, sodium acetate trihydrate, acetic acid, and water for injection.

Before you take TYMLOS, tell your healthcare provider about all of your medical conditions, including if you:
  • have Paget’s disease of the bone or other bone disease.
  • have or have had any of the following: cancer in your bones; radiation therapy involving your bones; too much calcium in your blood; or an increase in your parathyroid hormone (hyperparathyroidism).
  • will have trouble injecting yourself with the TYMLOS pen and do not have someone who can help you.
  • are pregnant or plan to become pregnant, because TYMLOS is not for pregnant women, or if you are breastfeeding or plan to breastfeed. It is not known if TYMLOS passes into your breast milk; you should not take TYMLOS and breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TYMLOS?
TYMLOS can cause serious side effects including:
  • Decrease in blood pressure when you change positions. Some people may feel dizzy, have a faster heartbeat, or feel lightheaded soon after the TYMLOS injection is given. These symptoms generally go away within a few hours. Take your injection of TYMLOS in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, stop taking TYMLOS and call your healthcare provider.
  • Increased blood calcium (hypercalcemia). TYMLOS can cause some people to have a higher blood calcium level than normal. Your healthcare provider may check your blood calcium before you start and during your treatment with TYMLOS. Tell your healthcare provider if you have nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs there is too much calcium in your blood.
  • Increased urine calcium (hypercalciuria). TYMLOS can cause some people to have higher levels of calcium in their urine than normal. Increased calcium may also cause you to develop kidney stones (urolithiasis) in your kidneys, bladder, or urinary tract. Tell your healthcare provider right away if you get any symptoms of kidney stones which may include pain in your lower back or lower stomach area, pain when you urinate, or blood in your urine.

The most common side effects of TYMLOS in women with postmenopausal osteoporosis include: dizziness, nausea, headache, fast heartbeat, feeling tired (fatigue), upper stomach pain, and spinning feeling (vertigo).

The most common side effects of TYMLOS in men with osteoporosis include: redness at injection site, dizziness, joint pain, swelling at injection site, pain at injection site, bruising, abdominal bloating, diarrhea, nausea, abdominal pain, and bone pain.

These are not all the possible side effects of TYMLOS. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

How should I use TYMLOS?
  • Read the complete Instructions for Use (opens in a new tab) provided with your medicine.
  • If you take more TYMLOS than prescribed you may experience symptoms such as muscle weakness, low energy, headache, nausea, dizziness (especially when getting up after sitting for a while), and a faster heartbeat. Stop taking TYMLOS and call your healthcare provider right away.
  • You should not use TYMLOS for more than 2 years over your lifetime.